IPS aligns with our interests in spreading positive awareness and information regarding psychedelics.
As an organization committed to the forefront of mental health innovation and advocacy, we proudly support the Illinois Psychedelic Society (IPS). Our partnership with IPS aligns with our mission to explore and implement groundbreaking treatments and therapies that can significantly improve quality of life. We believe in the transformative potential of psychedelics, backed by rigorous scientific research, to offer new, effective solutions for mental health challenges. Supporting IPS allows us to contribute to pivotal research, education, and policy reform efforts that pave the way for safe, regulated access to psychedelic therapies. This collaboration not only underscores our dedication to advancing mental health care but also reinforces our commitment to compassionate, evidence-based health solutions that can redefine the future of therapy and wellness.
Thank you for your hard work and dedication to this effort! It means a lot to me, and to all of the people who will benefit once this legislation gets passed. It gives me a real sense of optimism and hope.
Relief provides Spravato (intranasal esketamine) and IV ketamine for patients struggling with treatment-resistant depression and other mental health diagnoses. We'd like to support this organization and participate in its events to further psychedelic treatment awareness and education, and connect with other like-minded providers, professionals and community members.